Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLi, L.-
dc.contributor.authorWan, D.-
dc.contributor.authorPan, Z.-
dc.contributor.authorHardingham, J.-
dc.contributor.authorRieger, N.-
dc.contributor.authorHewett, P.-
dc.contributor.authorZhou, Y.-
dc.contributor.authorChen, G.-
dc.identifier.citationChinese journal of cancer, 2004; 23(11 [supp]):1502-1507-
dc.description.abstractBACKGROUND & OBJECTIVE: Although telomerase activity can be detected in 70%-90% malignant tumor tissues, it is still a controversial prognostic factor of patients with malignant tumors. This study was to evaluate clinical significance of human telomerase reverse transcriptase (hTERT) in patients with colon cancer. METHODS: Expression of hTERT in 59 matched pairs of tumor and adjacent non-tumorous mucosa samples from patients with colon cancer who underwent complete resection were measured by quantitative real-time reverse transcriptase-polymerase chain reaction (RT-PCR). RESULTS: Expression of hTERT in both tumor samples and nontumorous mucosa samples has no significant correlation with clinicopathologic factors. Of 32 patients with colon cancer of Dukes' A, and B stages, prognosis of 18 (56%) patients with hTERT expression of lower than 0.60 in tumor tissue was better than that of 27 (44%) patients with hTERT expression of higher than 0.60 (P=0.006), prognosis of 20 (62%) patients with the value of hTERT expression in tumor tissue subtracted from that in matched non-tumorous tissue below 0.50 was better than that of 12 (38%) patients with that value above 0.50 (P=0.035). In 27 patients with colon cancer of Dukes' C, and D stages, it was not practical to estimate the patients' prognosis with hTERT expression level in tumor tissue and the expression difference between tumor tissue and non-tumorous tissue. CONCLUSION: hTERT expression may be a potential prognostic index for patients with colon cancer of Dukes' A, and B stages.-
dc.publisherZhongshan Yike Daxue, Zhongliuzhi Zhongxin-
dc.subjectDNA binding protein-
dc.subjectcancer staging-
dc.subjectcolon tumor-
dc.subjectreverse transcription polymerase chain reaction-
dc.subjectColonic Neoplasms-
dc.subjectDNA-Binding Proteins-
dc.subjectNeoplasm Staging-
dc.subjectReverse Transcriptase Polymerase Chain Reaction-
dc.titleClinical significance of human telomerase reverse transcriptase in patients with colon cancer-
dc.typeJournal article-
dc.identifier.orcidHardingham, J. [0000-0001-8277-1199]-
Appears in Collections:Aurora harvest
Surgery publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.